Genome-wide association studies reveal distinct risk architectures: anti-MDA5-positive myositis associates with HLA-DRB104:05 in East Asian populations; anti-RNA polymerase III positivity in SSc links to POLR3A gene polymorphisms. The gene discussed is IFIH1; the disease is myositis disease.